Skin cutaneous melanoma had the most genetic alterations in the CILP2 gene, mainly in the form of mutations, whereas there were almost no alterations in acute myeloid leukemia, cholangiocarcinoma, renal cell carcinoma, pheochromocytoma, and paraganglioma. This evidence concerns the gene CILP2 and renal cell carcinoma.